(Q43580238)
Statements
Efficacy of low-dose erlotinib against gefitinib-induced hepatotoxicity in a patient with lung adenocarcinoma harboring EGFR mutations (English)
Hironori Kitade
Tadaaki Yamada
Saya Igarashi
Kengo Hokkoku
Mitsue Mori
Kimiko Shintaku
Motoyasu Sagawa
Masuo Nakai